[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-346489-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-346489-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","burden-and-risk-factor-patterns-of-reproductive-system-tumors-and-non-tumor-diseases-among-asian-women-evidence-from-the-gbd-study-1990-2021","Burden and Risk Factor Patterns of Reproductive System Tumors and Non-Tumor Diseases Among Asian Women - Evidence from the GBD Study 1990-2021","","Female reproductive system diseases—including malignant tumors such as breast, ovarian, and uterine cancers and nonneoplastic disorders like uterine fibroids, endometriosis, PCOS, infertility, and PMS—pose major health challenges across Asia. Using Global Burden of Disease (GBD) 2021 data from 47 Asian countries and territories (1990–2021), the study quantifies incidence, prevalence, mortality, and DALYs with age-standardized rates and EAPC trends. It evaluates burden patterns across SDI levels and links major modifiable risk factors to disease burden. In 2021, these diseases contributed over 33 million DALYs and ~600,000 deaths.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/burden-and-risk-factor-patterns-of-reproductive-system-tumors-and-non-tumor-diseases-among-asian-women-evidence-from-the-gbd-study-1990-2021/346489/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/burden-and-risk-factor-patterns-of-reproductive-system-tumors-and-non-tumor-diseases-among-asian-women-evidence-from-the-gbd-study-1990-2021/346489.png","ImageObject",300,407,{"name":42,"@type":43},"Finn","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",12,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What data source and study period were used to assess disease burden?","Question",{"text":63,"@type":64},"The analysis used Global Burden of Disease (GBD) 2021 data for 47 Asian countries and territories covering 1990–2021.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were disease burden trends evaluated over time?",{"text":68,"@type":64},"Incidence, prevalence, mortality, and DALYs were assessed along with age-standardized rates. Temporal trends were summarized using estimated annual percentage change (EAPC), and patterns were examined across SDI levels.",{"name":70,"@type":61,"acceptedAnswer":71},"Which conditions and risk factors showed notable burden patterns?",{"text":72,"@type":64},"Breast and cervical cancers contributed the most to mortality and DALYs, while PMS and infertility accounted for substantial burden among younger women. PCOS and infertility increased fastest; high BMI and elevated fasting glucose were strongly associated with breast and uterine cancer burden, and smoking was closely associated with cervical cancer burden.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},346489,1790493553,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},34359740700684,"https://ap-avatar.wpscdn.com/avatar/1f400023980c374ae676?_k=1777273430885731487","International Journal of Women’s Health  \n Open Access Full Text Article  \nORIGINAL RESEARCH  \nBurden and Risk Factor Patterns of Reproductive System Tumors and Non-Tumor Diseases Among Asian Women, 1990–2021: Evidence from the GBD Study  \nXinyi Xiong 1 , 2 , *, Yuming Yao2 , 3 , *, Guang Yang2 , 3 , Chiayen Lin2 ,4–6  \n1Department of Infectious Diseases, Xiangya Hospital, Central South University, Changsha, Hunan, People’s Republic of China; 2National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, People’s Republic of China; 3Department of Orthopedics, Xiangya Hospital, Central South University, Changsha, Hunan, People’s Republic of China; 4Department of General Surgery, Xiangya Hospital, Central South University, Changsha, Hunan, People’s Republic of China; 5Hunan Provincial Clinical Medical Research Centre for Thyroid Diseases, Changsha, Hunan, People’s Republic of China; 6Hunan Engineering Research Central for Thyroid and Related Diseases Diagnosis and Treatment Technology, Changsha, Hunan, People’s Republic of China  \n*These authors contributed equally to this work  \nCorrespondence: Chiayen Lin, Email [208122012@csu.edu.cn](208122012@csu.edu.cn)  \n\n| Background: Female reproductive system diseases, including malignant tumors such as breast, ovarian, and uterine cancers, and nonneoplastic disorders such as uterine fibroids, endometriosis, polycystic ovary syndrome (PCOS), infertility, and premenstrual syndrome (PMS), represent major health challenges in Asia. While malignant diseases receive considerable attention due to high mortality, the long-term burden of non-malignant conditions affecting fertility, psychological well-being, and quality of life remains underestimated. Methods: Data from the Global Burden of Disease (GBD) 2021 were used to quantify the burden of female reproductive system diseases in 47 Asian countries and territories from 1990 to 2021. Incidence, prevalence, mortality, and disability-adjusted life years (DALYs) were analyzed, together with age-standardized rates. Temporal trends were assessed using estimated annual percentage change (EAPC), and disease burden patterns were examined across Socio-demographic Index (SDI) levels. Associations between major modifiable risk factors and disease burden were described.\u003Cbr>Results: In 2021, female reproductive system diseases accounted for over 33 million DALYs and approximately 600,000 deaths in Asia. Breast and cervical cancers were the leading contributors to mortality and DALYs, whereas PMS and infertility accounted fora substantial burden among younger women. From 1990 to 2021, absolute case numbers and deaths increased with population growth and aging, while most age-standardized rates declined, particularly for cervical cancer. In contrast, PCOS and infertility showed the fastest increases. High body mass index and elevated fasting glucose were strongly associated with breast and uterine cancer burden, while smoking was closely associated with cervical cancer burden.\u003Cbr>Conclusion: Female reproductive system diseases impose a substantial and heterogeneous burden across Asia. Although malignant cancers remain the main contributors to mortality and DALYs, non-malignant disorders increasingly affect reproductive health, particularly among younger women. Prevention strategies tailored to SDI levels and major risk factors are needed to reduce the overall disease burden across the region.\u003Cbr>Keywords: female reproductive system diseases, global burden of disease, Asia, disability-adjusted life years, risk factors, women |\n| --- |\n| Introduction\u003Cbr>Female reproductive system diseases have emerged as a pressing global public health concern, posing significant challenges not only to physical health but also to broader aspects of women’s well-being.1 These conditions encompass both malignant tumors, such as breast and ovarian cancers, and a diverse spectrum of non-malignant gynecological disorders, i","cbCaifEHekHpxwJh","https://ap.wps.com/l/cbCaifEHekHpxwJh","pdf",8528684,17,"English","# Introduction\n# Methods\n# Results\n# Conclusion","[{\"question\":\"What data source and study period were used to assess disease burden?\",\"answer\":\"The analysis used Global Burden of Disease (GBD) 2021 data for 47 Asian countries and territories covering 1990–2021.\"},{\"question\":\"How were disease burden trends evaluated over time?\",\"answer\":\"Incidence, prevalence, mortality, and DALYs were assessed along with age-standardized rates. Temporal trends were summarized using estimated annual percentage change (EAPC), and patterns were examined across SDI levels.\"},{\"question\":\"Which conditions and risk factors showed notable burden patterns?\",\"answer\":\"Breast and cervical cancers contributed the most to mortality and DALYs, while PMS and infertility accounted for substantial burden among younger women. PCOS and infertility increased fastest; high BMI and elevated fasting glucose were strongly associated with breast and uterine cancer burden, and smoking was closely associated with cervical cancer burden.\"}]","Burden and Risk Factor Patterns of Reproductive System Tumors and Non-Tumor Diseases Among Asian Women - Evidence from the GBD Study 1990-2021 | PDF",1790061667,43,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e2d87712f76b00914150ea4707649a53.webp",983,1272,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0ac175c13d40e22d7c45cd687fa1cd96.webp",982,1270,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/707bc0344197ff2dd71cdf1d01fc18cb.webp",981,1269,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2f9a9625ff5b8ea7839c82c5b3f90278.webp",980,756]